MedPage Today (1/10, Walsh) reports that research suggests “long-term cutaneous fibrosis can occur following radiation therapy for breast cancer among women with scleroderma, although acute toxicity from radiation was rare and the autoimmune disease did not flare.” Researchers found that “few patients who received radiation had acute skin toxicity such as blistering or ulceration, but” approximately “half (48.4% to 54.6%) experienced long-term radiation-induced skin fibrosis or thickening that was localized to the field of radiation.” At one year “after the cancer diagnosis, there was no evidence of scleroderma disease flare, in that no significant difference was seen on modified Rodnan skin scores between patients who had received radiation and those without radiation.” The findings were published online in Arthritis Care & Research.
HealthDay (1/10, Dallas) reports that research suggests “women who are unhappy with the size of their breasts – whether too big or too small – may be less likely to perform self-exams to check for signs of breast cancer.” The research also indicated that “these women are...more likely to put off seeing a doctor if they do find a suspicious lump in their breast.” The findings were published in Body Image.
Aunt Minnie (1/10, Kim) reports that researchers have created a “3D-printed robot-guided device capable of facilitating MR-guided breast biopsy and improving the accuracy of breast cancer diagnosis.” The group includes Vincent Groenhuis, Françoise Siepel, PhD, and Stefano Stramigioli, PhD, from the Robotics and Mechatronics laboratory at the University of Twente in the Netherlands. The article says, “In a proof-of-concept study, the researchers found that the device was able to maneuver a needle toward target coordinates inside the breast with extreme precision on a single attempt.” The device is called Stormram 4 and it won the Surgical Robot Challenge at the 2017 Hamlyn Symposium in London, “a major event in the field of robotic surgery.”
HealthDay (1/9, Thompson) reports a study published Jan. 9 in the Journal of the American Medical Association found that “screening and treatment reduced breast cancer deaths by 49 percent in 2012, compared with a 37 percent reduction in 2000.” Additionally, “treatments that target specific types of breast cancer have generated the most scientific advancement and, as such, have taken a larger role in saving lives, the researchers found,” with better cancer treatments accounting “for 63 percent of the reduction in breast cancer deaths in 2012, compared with 37 percent due to early detection of cancer through screening.”
TIME (1/8, Park) reports that research suggests “women who work the night shift have a 19% increased risk of developing cancer compared to women do not work at night.” The findings were published in Cancer Epidemiology, Biomarkers & Prevention. After analyzing data from 61 studies, researchers “found that women who worked night shifts for longer periods of time had a 41% higher risk of skin cancer, 32% higher risk of breast cancer and an 18% greater risk of digestive system cancers compared to women who did not work night shifts.” The data indicated that “the risk was highest among nurses who worked at night; their risk of developing breast cancer if they worked night shifts long term was 58% higher than nurses who didn’t have night shifts.”
HealthDay (1/8, Dallas) reports that the studies analyzed included “people from North America, Europe, Australia and Asia.” When the investigators “took into account for location, they found that only the night-shift workers from North America and Europe had a greater risk for breast cancer.” Medscape (1/8, Jenkins) also covers the story.